Hence, miR-122, uptaken by surrounding cells, targets PKM2 and represses glycolytic metabolism, thereby lowering glucose utilization by niche cells and allowing glucose exploitation by growing cancer cells [106]. The gene discussed is PKM; the disease is cancer.